Hospital costs and outcomes among intravenous antifungal therapies for patients with invasive aspergillosis in the United States
Open accessAbstract
Summary: This study determined the economic burden of aspergillosis‐related hospitalisations in the United States during years when new antifungal treatments were introduced. A retrospective observational cohort study from the hospital perspective was conducted using national administrative data from the Premier Perspective™ Database. Patients (n = 1603) coded for infection caused by Aspergillus species during 1835 admissions who received at least 3 days of intravenous antifungal therapy between 2000 and 2006 were included. All costs were inflated to $US 2006. Length of stay, hospital costs and mortality were compared after stratification by initial antifungal therapy. Median hospital costs were $52 803 (25 929–100 730) and did not differ by year over the study period. Intravenous antifungals accounted for 7.2% (range: 0.78–15.9%) of the cost of aspergillosis‐related hospitalisation. Crude mortality was 36.7% and was the lowest in the last 2 years of the study (2005, 2006). Although antifungal utilisation changed over the course of the study, initial antifungal choice was not independently associated with crude mortality. In contrast, initial therapy with intravenous voriconazole was associated with reduced total hospitalisation costs and length of hospital stay. Treatment with amphotericin B lipid complex or caspofungin was also independently associated with a reduced length of hospital stay. In this large US study, mortality and costs for aspergillosis‐related hospitalisations were considerable, but antifungals accounted for a small percentage of total costs associated with treatment and did not independently affect in‐hospital crude mortality. Only initial treatment with intravenous voriconazole was associated with reduced total hospitalisation costs.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Voriconazole versus Amphotericin B for Primary Therapy of Invasive Aspergillosis
Herbrecht, R., Denning, D. W., Patterson, T. F., Bennett, J. E., Greene, R. E., Oestmann, J.-W., Kern, W. V., Marr, K. A., Ribaud, P., Lortholary, O., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa020191 · Cited by 3,304 · see citing works
Walsh, T. J., Anaissie, E. J., Denning, D. W., Herbrecht, R., Kontoyiannis, D. P., Marr, K. A., Morrison, V. A., Segal, B. H., Steinbach, W. J., Stevens, D. A., et al. (2008) · Clinical Infectious Diseases · doi:10.1086/525258 · Cited by 2,685 · see citing works
Aspergillosis Case-Fatality Rate: Systematic Review of the Literature
Lin, S., Schranz, J., & Teutsch, S. M. (2001) · Clinical Infectious Diseases · doi:10.1086/318483 · Cited by 1,408 · see citing works
Practice Guidelines for Diseases Caused by Aspergillus
Stevens, D. A., Kan, V. L., Judson, M. A., Morrison, V. A., Dummer, S. J., Denning, D. W., Bennett, J. E., Walsh, T. J., Patterson, T. F., & Pankey, G. A. (2000) · Clinical Infectious Diseases · doi:10.1086/313756 · Cited by 786 · see citing works
Wingard, J. R., White, M. H., Anaissie, E. J., Raffalli, J. T., Goodman, J., Arrieta, A. C., & L Amph/ABLC Collaborative Study Group (2000) · Clinical Infectious Diseases · doi:10.1086/317451 · Cited by 524 · see citing works
The direct cost and incidence of systemic fungal infections
Wilson, L. S., Reyes, C. M., Stolpman, M., Speckman, J., Allen, K., & Beney, J. (2002) · Value in Health · doi:10.1046/j.1524-4733.2002.51108.x · Cited by 374 · see citing works
Minari, A., Husni, R., Avery, R. K., Longworth, D. L., DeCamp, M. M., Bertin, M. L., Schilz, R. J., Smedira, N. G., Haug, M., Mehta, A. C., et al. (2002) · Transplant Infectious Disease · doi:10.1034/j.1399-3062.2002.t01-2-02002.x · Cited by 350 · see citing works
Factors Associated with Overall and Attributable Mortality in Invasive Aspergillosis
Nivoix, Y., Velten, M., Letscher‐Bru, V., Moghaddam, A. Z., Natarajan‐Amé, S., Fohrer, C., Lioure, B., Bilger, K., Lutun, P., Marcellin, L., et al. (2008) · Clinical Infectious Diseases · doi:10.1086/592255 · Cited by 340 · see citing works
Marr, K. A., Patterson, T. F., & Denning, D. W. (2002) · Infectious Disease Clinics of North America · doi:10.1016/s0891-5520(02)00035-1 · Cited by 310 · see citing works
Steinbach, W. J., Stevens, D. A., & Denning, D. W. (2003) · Clinical Infectious Diseases · doi:10.1086/376524 · Cited by 192 · see citing works
Burden of aspergillosis-related hospitalizations in the United States
Dasbach, E. J., Davies, G. M., & Teutsch, S. M. (2000) · Clinical Infectious Diseases · doi:10.1086/317487 · Cited by 159 · see citing works
Baram, D., Daroowalla, F., Garcia, R., Zhang, G., Chen, J. J., Healy, E., Riaz, S. A., & Richman, P. S. (2008) · Clinical Medicine Insights Circulatory Respiratory and Pulmonary Medicine · doi:10.4137/ccrpm.s544 · Cited by 147 · see citing works
Making sense of itraconazole pharmacokinetics
Prentice, A. G., & Glasmacher, A. G. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki220 · Cited by 143 · see citing works
Fleming, R. V., Kantarjian, H. M., Husni, R., Rolston, K. V. I., Lim, J. T., RAAD, I. I., Pierce, S. A., Cortes, J. E., & Estey, E. H. (2001) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428190109097650 · Cited by 134 · see citing works
Edelsberg, J., Berger, A., Weber, D. J., Mallick, R., Kuznik, A., & Oster, G. (2007) · Infection Control and Hospital Epidemiology · doi:10.1086/526444 · Cited by 115 · see citing works
Slobbe, L., Polinder, S., Doorduijn, J. K., Lugtenburg, P. J., el Barzouhi, A., Steyerberg, E. W., & Rijnders, B. J. A. (2008) · Clinical Infectious Diseases · doi:10.1086/591531 · Cited by 90 · see citing works
Wenzel, R. P., Favero, A. D., Kibbler, C. C., Rogers, T. R., Rotstein, C., Mauskopf, J., Stephen Morris, A., Schlamm, H. T., Troke, P. F., & Marciniak, A. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkh535 · Cited by 66 · see citing works
The economic impact of aspergillosis: analysis of hospital expenditures across patient subgroups
Tong, K. B., Lau, C., Murtagh, K. N., Layton, A. J., & Seifeldin, R. (2008) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2008.02.013 · Cited by 65 · see citing works
The place for itraconazole in treatment
Maertens, J. A., & Boogaerts, M. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki222 · Cited by 35 · see citing works
Wingard, J. R., Herbrecht, R., Mauskopf, J., Schlamm, H. T., Marciniak, A., & Roberts, C. S. (2007) · Transplant Infectious Disease · doi:10.1111/j.1399-3062.2007.00210.x · Cited by 27 · see citing works
Ament, A. J. H. A., Hübben, M. W. A., Verweij, P. E., de Groot, R., Warris, A., Donnelly, J. P., Wout, J. V. ’., & Severens, J. L. (2007) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkm196 · Cited by 17 · see citing works
Greene, R. E., Mauskopf, J., Roberts, C. S., Zyczynski, T. M., & Schlamm, H. T. (2007) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp060584 · Cited by 16 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Estimation of Direct Healthcare Costs of Fungal Diseases in the United States
Benedict, K., Jackson, B. R., Chiller, T., & Beer, K. D. (2019) · Clinical Infectious Diseases · doi:10.1093/cid/ciy776 · Cited by 438 · see citing works
“Other studies of aspergillosis-related hospitalizations using administrative data found a median cost of $52,803 (inflation-adjusted to $74,653 in 2017 dollars) in 2006 [6] and a mean of $76,235 ($99,532 in 2017 dollars) specifically among intensive care unit patients during 2005–2008, [19] compared with a mean all-pa…”
BackgroundTaccone, F. S., den Abeele, A. V., Bulpa, P., Misset, B., Meersseman, W., Cardoso, T., Paiva, J.-A., Blasco-Navalpotro, M. Á., Laere, E. D., Dimοpoulos, G., et al. (2015) · Critical Care · doi:10.1186/s13054-014-0722-7 · Cited by 405 · see citing works
Aspergillosis in Intensive Care Unit (ICU) patients: epidemiology and economic outcomes
Baddley, J. W., Stephens, J., Ji, X., Gao, X., Schlamm, H. T., & Tarallo, M. (2013) · BMC Infectious Diseases · doi:10.1186/1471-2334-13-29 · Cited by 144 · see citing works
The case for antifungal stewardship
Ananda-Rajah, M. R., Slavin, M. A., & Thursky, K. (2011) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0b013e32834e0680 · Cited by 128 · see citing works
Laboratory Diagnosis of Invasive Aspergillosis: From Diagnosis to Prediction of Outcome
Barton, R. (2013) · Scientifica · doi:10.1155/2013/459405 · Cited by 122 · see citing works
Reinwald, M., Hummel, M., Kovalevskaya, E., Spieß, B., Heinz, W., Vehreschild, J. J., Schultheis, B. S., Krause, S. W., Claus, B., Suedhoff, T., et al. (2012) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dks208 · Cited by 94 · see citing works
Ananda-Rajah, M. R., Cheng, A., Morrissey, C. O., Spelman, T. D., Dooley, M. J., Neville, A. M., & Slavin, M. A. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01423-10 · Cited by 85 · see citing works
Approach to invasive pulmonary aspergillosis in critically ill patients
Koulenti, D., Garnacho‐Montero, J., & Blot, S. I. (2014) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0000000000000043 · Cited by 81 · see citing works
Epidemiology and burden of invasive fungal infections in the countries of the Arab League
Kmeid, J., Jabbour, J.-F., & Kanj, S. S. (2019) · Journal of Infection and Public Health · doi:10.1016/j.jiph.2019.05.007 · Cited by 70 · see citing works
van der Elst, K. C. M., Span, L. F. R., van Hateren, K., Vermeulen, K. M., van der Werf, T. S., Greijdanus, B., Kosterink, J. G. W., Uges, D. R. A., & Alffenaar, J. C. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00707-13 · Cited by 63 · see citing works
Sun, K.-S., Tsai, C.-F., Chen, S. C., & Huang, E. W.-C. (2017) · PLoS ONE · doi:10.1371/journal.pone.0186422 · Cited by 59 · see citing works
Galactomannan in Bronchoalveolar Lavage for Diagnosing Invasive Fungal Disease
Affolter, K., Tamm, M., Jahn, K., Halter, J., Passweg, J., Hirsch, H. H., & Stolz, D. (2014) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201403-0431oc · Cited by 51 · see citing works
Doan, T. N., Kirkpatrick, C. M. J., Walker, P., Slavin, M. A., Ananda-Rajah, M. R., Morrissey, C. O., Urbancic, K. F., Grigg, A., Spencer, A. G., Szer, J., et al. (2015) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkv343 · Cited by 42 · see citing works
Παπαδοπούλου, Α., Kaloyannidis, P., Yannaki, E., & Cruz, C. C. (2015) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2015.10.005 · Cited by 41 · see citing works
Buess, M., Cathomas, G., Halter, J. P., Junker, L., Grendelmeier, P. S., Tamm, M., & Stolz, D. (2012) · BMC Infectious Diseases · doi:10.1186/1471-2334-12-237 · Cited by 38 · see citing works
Harrington, R. L., Lee, E. W., Yang, H., Wei, J., Messali, A. J., Azie, N. E., Wu, E. Q., & Spalding, J. R. (2016) · Advances in Therapy · doi:10.1007/s12325-016-0443-1 · Cited by 36 · see citing works
Krishnan, K., & Askew, D. S. (2014) · Virulence · doi:10.4161/viru.26571 · Cited by 35 · see citing works
Antifungal therapy and length of hospitalization in transplant patients with invasive aspergillosis
Baddley, J. W., Andes, D. R., Marr, K. A., Kauffman, C. A., Kontoyiannis, D. P., Ito, J. I., Schuster, M. G., Brizendine, K. D., Patterson, T. F., Lyon, G. M., et al. (2013) · Medical Mycology · doi:10.3109/13693786.2012.690108 · Cited by 34 · see citing works
Subtherapeutic Posaconazole Exposure and Treatment Outcome in Patients With Invasive Fungal Disease
van der Elst, K. C. M., Brouwers, C. H. S., van den Heuvel, E. R., van Wanrooy, M. J. P., Uges, D. R. A., van der Werf, T. S., Kosterink, J. G. W., Span, L. F. R., & Alffenaar, J. C. (2015) · Therapeutic Drug Monitoring · doi:10.1097/ftd.0000000000000235 · Cited by 33 · see citing works
Epidemiology, Drug Susceptibility, and Clinical Risk Factors in Patients With Invasive Aspergillosis
Wang, Y., Zhang, L., Zhou, L., Zhang, M., & Xu, Y. (2022) · Frontiers in Public Health · doi:10.3389/fpubh.2022.835092 · Cited by 33 · see citing works
Identification of New Antifungal Compounds Targeting Thioredoxin Reductase of Paracoccidioides Genus
Abadio, A. K. R., Kioshima, É. S., Leroux, V., Martins, N. F., Maigret, B., & Felipe, M. S. S. (2015) · PLoS ONE · doi:10.1371/journal.pone.0142926 · Cited by 33 · see citing works
Souza, A. C. O., Martín‐Vicente, A., Nywening, A. V., Ge, W., Lowes, D. J., Peters, B. M., & Fortwendel, J. R. (2021) · PLoS Pathogens · doi:10.1371/journal.ppat.1009806 · Cited by 32 · see citing works
Balogh, J., Burroughs, S. G., Boktour, M. R., Patel, S. S., Saharia, A., Ochoa, R. A., McFadden, R., Victor, D. W., Ankoma‐Sey, V., Galati, J., et al. (2015) · Liver Transplantation · doi:10.1002/lt.24365 · Cited by 31 · see citing works
Advances in the Diagnosis and Management of Pulmonary Aspergillosis
Gao, Y., & Soubani, A. O. (2020) · Advances in respiratory medicine · doi:10.5603/arm.2019.0061 · Cited by 29 · see citing works
Krishnan, K., Ren, Z., Losada, L. C., Nierman, W. C., Lu, L. J., & Askew, D. S. (2014) · BMC Genomics · doi:10.1186/1471-2164-15-159 · Cited by 26 · see citing works
Sun, K.-S., Tsai, C.-F., Chen, S. C., Chen, Y.-Y., & Huang, E. W.-C. (2016) · PLoS ONE · doi:10.1371/journal.pone.0149964 · Cited by 26 · see citing works
Al-Abdely, H. M., Alothman, A. F., Salman, J. A., Al-Musawi, T., AlMaslamani, M. A. R. S., Butt, A. A., Althaqafi, A. O., Raghubir, N., Morsi, W. E., & Yared, N. (2013) · Journal of Infection and Public Health · doi:10.1016/j.jiph.2013.08.003 · Cited by 25 · see citing works
Heinz, W., Buchheidt, D., & Ullmann, A. J. (2016) · Mycoses · doi:10.1111/myc.12477 · Cited by 25 · see citing works
Ceesay, M. M., Sadique, Z., Harris, R., Ehrlich, A., Adams, E. J., & Pagliuca, A. (2014) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dku506 · Cited by 23 · see citing works
Παπαδοπούλου, Α., Alvanou, M. V., Koukoulias, K., Athanasiou, E., Lazaridou, A., Savvopoulos, N., Kaloyannidis, P., Markantonatou, A., Vyzantiadis, T., Yiangou, M., et al. (2019) · Bone Marrow Transplantation · doi:10.1038/s41409-019-0501-9 · Cited by 23 · see citing works
Horn, D., Goff, D. A., Khandelwal, N., Spalding, J. R., Azie, N. E., Shi, F., Franks, B., & Shorr, A. F. (2016) · Journal of Medical Economics · doi:10.3111/13696998.2016.1164175 · Cited by 20 · see citing works
Valentine, J. C., Morrissey, C. O., TACEY, M. A., Liew, D., Patil, S. S., & Ananda-Rajah, M. R. (2019) · Mycoses · doi:10.1111/myc.13033 · Cited by 16 · see citing works
Surgical resection for patients with pulmonary aspergillosis in the national inpatient sample
Patel, D. C., Bhandari, P., Epstein, D. J., Liou, D. Z., Backhus, L. M., Berry, M. F., Shrager, J. B., & Lui, N. S. (2021) · Journal of Thoracic Disease · doi:10.21037/jtd-21-151 · Cited by 15 · see citing works
Epidemiology of Pulmonary Aspergillosis in Hospitalized Patients in Poland During 2009–2016
Tarka, P., Nitsch-Osuch, A. S., Goryński, P., Tyszko, P. Z., Bogdan, M., & Kanecki, K. (2019) · Advances in experimental medicine and biology · doi:10.1007/5584_2019_347 · Cited by 15 · see citing works
Heng, S. C., Slavin, M. A., Chen, S. C. A., Heath, C. H., Nguyen, Q. A., Billah, B., Nation, R. L., & Kong, D. C. M. (2012) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dks210 · Cited by 14 · see citing works
A score for predicting invasive pulmonary aspergillosis in immunocompetent critically ill patients
Li, W., Chen, G., Lin, F., Yang, H., Cui, Y., Lu, R., Song, C., Li, H., Li, Y., & Pan, P. (2023) · European Journal of Clinical Investigation · doi:10.1111/eci.13985 · Cited by 12 · see citing works
Marshall, A. C., Kroker, A. J., Murray, L. A. M., Gronthos, K., Rajapaksha, H., Wegener, K. L., & Bruning, J. B. (2017) · FEBS Journal · doi:10.1111/febs.14035 · Cited by 11 · see citing works
Lundberg, J., Höglund, M., Björkholm, M., & Åkerborg, Ö. (2014) · Clinical Drug Investigation · doi:10.1007/s40261-014-0199-9 · Cited by 9 · see citing works
Antifungal Stewardship in Low- and Middle-Income Countries
Riera, F. O., Caeiro, J. P., & Sotomayor, C. E. (2019) · Current treatment options in infectious diseases/Current treatment options in infectious disease · doi:10.1007/s40506-019-00197-2 · Cited by 8 · see citing works
Houghton, K., Esterberg, E. J., Ajmera, M., Candrilli, S. D., Kitt, T. M., Spalding, J. R., & Pérez, V. (2019) · Infectious Diseases and Therapy · doi:10.1007/s40121-019-00267-4 · Cited by 8 · see citing works
Mistro, S., Rosa, L., Gomes, B., Miranda, L. A. V. D. O., & Badaró, R. J. D. S. (2016) · Expert Review of Pharmacoeconomics & Outcomes Research · doi:10.1080/14737167.2016.1202766 · Cited by 8 · see citing works
Chen, W.-C., Chen, I., Chen, J., Liao, T., & Chen, Y. (2024) · PeerJ · doi:10.7717/peerj.17066 · Cited by 6 · see citing works
Ueno, R., Nishimura, S., Fujimoto, G., & Ainiwaer, D. (2021) · Current Medical Research and Opinion · doi:10.1080/03007995.2021.1927691 · Cited by 6 · see citing works
Pharmacoeconomic assessment of therapy for invasive aspergillosis
Luong, M., Husain, S., & Rotstein, C. (2013) · Mycoses · doi:10.1111/myc.12036 · Cited by 6 · see citing works
Сергеевич, К. И., Климко, Н. Н., Ermakova, V. Y., & Сергеевна, К. В. (2019) · Oncohematology · doi:10.17650/1818-8346-2019-14-1-49-59 · Cited by 4 · see citing works
An Invisible Threat: Mutation-Mediated Resistance to Triazole Drugs in Aspergillus
Pham, C. D., & Lockhart, S. R. (2012) · Current Fungal Infection Reports · doi:10.1007/s12281-012-0106-x · Cited by 4 · see citing works
Edinger, S., Abdala, E., Ertürk, U. Ş., Çelik, S., Kaynar, L., Ricardo Rabagliati, B., Badali, H., Amanati, A., Ruiz, A. M. H., Meletiadis, J., et al. (2025) · Revista Iberoamericana de Micología · doi:10.1016/j.riam.2025.04.003 · Cited by 3 · see citing works
Munir, G., Farhad, S., Alam, S., Azim, A., Hussain, S., Khan, S. A., Raziq, K., Bangash, S. A., Llah, I.-U., & Mir, H. (2022) · Pakistan Journal of Medical and Health Sciences · doi:10.53350/pjmhs22167634 · Cited by 2 · see citing works
Borys, M., Piwowarczyk, P., Sysiak-Sławecka, J., Czuczwar, M., & Prystupa, A. (2017) · Annals of Agricultural and Environmental Medicine · doi:10.5604/12321966.1233966 · Cited by 2 · see citing works
Epidemiologic Research of Invasive Fungal Infections Using Large Healthcare Databases
Min, Z., Curtis, J. R., & Baddley, J. W. (2013) · Current Fungal Infection Reports · doi:10.1007/s12281-013-0156-8 · Cited by 1 · see citing works
Сергеевич, К. И., Макарова, Е. В., Ermakova, V. Y., Сергеевна, К. В., & Климко, Н. Н. (2021) · Oncohematology · doi:10.17650/1818-8346-2021-16-2-94-107 · Cited by 1 · see citing works
Host Factors in Defense against Bacterial and Fungal Pneumonia
Bettina, A. M. (2016) · doi:10.18130/v3pc7z · Cited by 1 · see citing works
Durden, E., McMorrow, D., Juneau, P. L., Fowler, R., Chaudhari, P., & Horn, D. (2013) · Journal of health economics and outcomes research · doi:10.36469/9862
Al-Sofyani, K. A., Uddin, M. S., Alghamdi, H. S., & El-Hossary, D. (2020) · Acta Scientific Paediatrics · doi:10.31080/aspe.2020.03.0318
Gonzalez, B. E., Cabral, L., & Auletta, J. J. (2014) · Pediatric oncology · doi:10.1007/978-3-662-44317-0_1
Akram, W., Khan, A. H., Safdar, A., Mallhi, T. H., Sulaiman, S. A. S., & Muqeet, N. (2022) · Journal of Applied Pharmaceutical Science · doi:10.7324/japs.2022.121109
Vahedi‐Shahandashti, R., Houbraken, J. A. M. P., Hubka, V., Meijer, M., Zelger, B. G., Binder, U., & Lass‐Flörl, C. (2025) · Microbiology Spectrum · doi:10.1128/spectrum.02576-24
He, C., Liu, X., Wang, B., Hu, L., Zhang, J., Zeng, X., & Wan, B. (2026) · BMC Infectious Diseases · doi:10.1186/s12879-026-14059-y
- Authors
- Kim, A., Nicolau, D. P., & Kuti, J. L.
- Affiliations
- Hartford Hospital (US)
- Corresponding author
- Kuti, Joseph L.
- Venue
- Mycoses
- Publisher
- Wiley
- Published
- 2011-09
- Volume
- 54
- Issue
- 5
- Pages
- e301-12
- ISSN
- 0027-5557 (ISSN-L)
- 0933-7407
- 1439-0507
- OpenAlex
- W1550951130
- Semantic Scholar
- 71f0df4b6c77579a4c54bfd307e2f23efa3b7f60
- Cited by
- 60
- References
- 22
- Citations by year
- 2026: 1 · 2025: 2 · 2024: 1 · 2023: 1 · 2022: 3 · 2021: 4 · 2020: 2 · 2019: 8 · 2018: 1 · 2017: 3 · 2016: 6 · 2015: 7 · 2014: 6 · 2013: 9 · 2012: 4
- FWCI
- 3.13
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Mycoses (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Enzon Pharmaceuticals
- Astellas Pharma
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life
- Health Sciences › Medicine › Ophthalmology › Ocular Infections and Treatments
- Keywords
- invasive aspergillosis, intravenous antifungal therapy, hospital costs, length of hospital stay, mortality, voriconazole, amphotericin B lipid complex, caspofungin, economic burden, aspergillosis
- MeSH terms
- Caspofungin, Adult, Aged, Amphotericin B, Antifungal Agents, Female, Humans, Infusions, Intravenous, Length of Stay, Male, Middle Aged, Pyrimidines, Retrospective Studies, Triazoles, United States, Cohort Studies, Treatment Outcome, Hospital Costs, Echinocandins, Lipopeptides, Invasive Pulmonary Aspergillosis, Voriconazole
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
